HCAT logo

Health Catalyst, Inc. Stock Price

NasdaqGS:HCAT Community·US$130.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

HCAT Share Price Performance

US$1.90
-1.91 (-50.13%)
US$2.00
Fair Value
US$1.90
-1.91 (-50.13%)
5.0% undervalued intrinsic discount
US$2.00
Fair Value
Price US$1.90
AnalystHighTarget US$2.00
AnalystConsensusTarget US$1.75
AnalystLowTarget US$1.00

HCAT Community Narratives

·
Fair Value US$2 5.0% undervalued intrinsic discount

Accelerating AI Adoption And Digital Transformation Will Expand Healthcare Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$1.75 8.6% overvalued intrinsic discount

Modular AI Solutions Will Transform Value-Based Healthcare

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
·
Fair Value US$1 90.0% overvalued intrinsic discount

Medicaid Cuts Will Constrict Deals But Spur Efficiency

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

Updated Narratives

HCAT logo

HCAT: Cost Restructuring And Governance Changes Will Shape A Measured Turnaround

Fair Value: US$1.75 8.6% overvalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HCAT logo

HCAT: Execution On Product Transition And Cost Cuts Will Shape 2026 Reset

Fair Value: US$2 5.0% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HCAT logo

HCAT: Guidance Reset And Impairment Charges Will Pressure Shares Further

Fair Value: US$1 90.0% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

2 Risks
0 Rewards

Health Catalyst, Inc. Key Details

US$302.5m

Revenue

US$149.9m

Cost of Revenue

US$152.6m

Gross Profit

US$417.8m

Other Expenses

-US$265.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-3.59
50.44%
-87.69%
111.0%
View Full Analysis

About HCAT

Founded
2008
Employees
1200
CEO
Benjamin Albert
WebsiteView website
www.healthcatalyst.com

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Recent HCAT News & Updates

Narrative Update Jun 23

HCAT: Cost Restructuring And Governance Changes Will Shape A Measured Turnaround

Analysts have trimmed their 12 month price target on Health Catalyst by $0.25, citing updated assumptions around fair value, growth expectations, profitability and future P/E multiples. What’s in the News for Health Catalyst Health Catalyst has scheduled its 2026 Annual Meeting of Stockholders for July 16, 2026, to be held via a live interactive audio webcast.
Narrative Update Jun 05

HCAT: Execution On Product Transition And Cost Cuts Will Shape 2026 Reset

Analysts have trimmed Health Catalyst's implied fair value to $2.00 per share from $5.00. This reflects a higher discount rate, a cut to longer term revenue expectations after softer Q1 guidance and a delayed FY26 outlook, and lower assumed future P/E multiples despite relatively stable profit margin assumptions.

Recent updates

No updates